References
- Kuhn J. History of filoviral disease outbreaks. In: Calisher C, editor. Filoviruses - a compendium of 40 years of epidemiological, clinical, and laboratory studies. Vienna: SpringerWienNewYork; 2008.
- WHO. Ground zero in Guinea: the Ebola outbreak smoulders – undetected – for more than 3 months. Geneva (Switzerland): World Health Organization; 2014.
- WHO. Statement on the 1st meeting of the IHR Emergency Committee on the 2014 Ebola outbreak in West Africa. Geneva (Switzerland): World Health Organization; 2014.
- WHO. Ebola situation report, 30 March 2016. Geneva (Switzerland): World Health Organization; 2016.
- Marzi A, Feldmann H. Ebola virus vaccines: an overview of current approaches. Expert Rev Vaccines. 2014;13(4):521–531.
- Henao-Restrepo AM, Preziosi MP, Wood D, et al. WHO Ebola Research DT. On a path to accelerate access to Ebola vaccines: the WHO’s research and development efforts during the 2014-2016 Ebola epidemic in West Africa. Curr Opin Virol. 2016;17:138–144.
- Stanley DA, Honko AN, Asiedu C, et al. Chimpanzee adenovirus vaccine generates acute and durable protective immunity against Ebola virus challenge. Nat Med. 2014;20(10):1126–1129.
- Geisbert TW, Feldmann H. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections. J Infect Dis. 2011;204(Suppl 3):S1075–S1081.
- Regules JA, Beigel JH, Paolino KM, et al. A recombinant vesicular stomatitis virus Ebola vaccine. N Engl J Med. 2017 Jan 26;376(4):330–341.
- Agnandji ST, Huttner A, Zinser ME, et al. Phase 1 trials of rVSV Ebola vaccine in Africa and Europe. N Engl J Med. 2016 Apr 28;374(17):1647–1660.
- Ledgerwood JE, DeZure AD, Stanley DA, et al. Chimpanzee adenovirus vector Ebola vaccine. N Engl J Med. 2017 Mar 9;376(10):928–938.
- Henao-Restrepo AM, Longini IM, Egger M, et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. Lancet. 2015;386(9996):857–866.
- Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!). Lancet. 2017 Feb 4;389(10068):505–518.
- Gavi. Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks. Geneva (Switzerland): Gavi - The Vaccine Alliance; 2016.